These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 20523738

  • 1. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
    Oliveira ML, Miyaji EN, Ferreira DM, Moreno AT, Ferreira PC, Lima FA, Santos FL, Sakauchi MA, Takata CS, Higashi HG, Raw I, Kubrusly FS, Ho PL.
    PLoS One; 2010 May 27; 5(5):e10863. PubMed ID: 20523738
    [Abstract] [Full Text] [Related]

  • 2. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
    Salcedo-Rivillas C, Debrie AS, Miyaji EN, Ferreira JM, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira ML.
    Clin Vaccine Immunol; 2014 Jul 27; 21(7):972-81. PubMed ID: 24807055
    [Abstract] [Full Text] [Related]

  • 3. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
    Lima FA, Miyaji EN, Quintilio W, Raw I, Ho PL, Oliveira ML.
    Vaccine; 2013 May 07; 31(20):2465-70. PubMed ID: 23541622
    [Abstract] [Full Text] [Related]

  • 4. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO, Rodrigues TC, da Silva JB, Schanoski AS, Oliveira ML, Miyaji EN.
    PLoS One; 2017 May 07; 12(1):e0170157. PubMed ID: 28103277
    [Abstract] [Full Text] [Related]

  • 5. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
    Moreno AT, Oliveira ML, Ferreira DM, Ho PL, Darrieux M, Leite LC, Ferreira JM, Pimenta FC, Andrade AL, Miyaji EN.
    Clin Vaccine Immunol; 2010 Mar 07; 17(3):439-46. PubMed ID: 20089795
    [Abstract] [Full Text] [Related]

  • 6. Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA.
    Carneiro GB, Castro JT, Davi M, Miyaji EN, Ladant D, Oliveira MLS.
    Vaccine; 2023 Jun 23; 41(28):4170-4182. PubMed ID: 37236818
    [Abstract] [Full Text] [Related]

  • 7. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B, Chen X, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Wu Y.
    Microb Pathog; 2018 Oct 23; 123():115-119. PubMed ID: 29959043
    [Abstract] [Full Text] [Related]

  • 8. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
    Lu J, Guo J, Wang D, Yu J, Gu T, Jiang C, Kong W, Wu Y.
    Hum Vaccin Immunother; 2019 Oct 23; 15(2):371-380. PubMed ID: 30235046
    [Abstract] [Full Text] [Related]

  • 9. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 Oct 23; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    Castro JT, Oliveira GS, Nishigasako MA, Debrie AS, Miyaji EN, Soares-Schanoski A, Akamatsu MA, Locht C, Ho PL, Mielcarek N, Oliveira MLS.
    PLoS One; 2020 Oct 23; 15(1):e0228055. PubMed ID: 31945121
    [Abstract] [Full Text] [Related]

  • 11. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J, Chen X, Li B, Gu T, Meng X, Kong W, Wu Y.
    Immunol Res; 2018 Aug 23; 66(4):528-536. PubMed ID: 30128745
    [Abstract] [Full Text] [Related]

  • 12. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
    Piao Z, Akeda Y, Takeuchi D, Ishii KJ, Ubukata K, Briles DE, Tomono K, Oishi K.
    Vaccine; 2014 Sep 29; 32(43):5607-13. PubMed ID: 25132335
    [Abstract] [Full Text] [Related]

  • 13. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.
    Infect Immun; 2012 Mar 29; 80(3):1166-80. PubMed ID: 22158740
    [Abstract] [Full Text] [Related]

  • 14. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 15. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.
    Miyaji EN, Ferreira DM, Lopes AP, Brandileone MC, Dias WO, Leite LC.
    Infect Immun; 2002 Sep 05; 70(9):5086-90. PubMed ID: 12183557
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF, Ferreira DM, Moreno AT, Chavez-Olortegui C, Machado de Avila RA, Oliveira ML, Ho PL, Miyaji EN.
    Microb Pathog; 2012 Sep 05; 53(5-6):243-9. PubMed ID: 22981893
    [Abstract] [Full Text] [Related]

  • 17. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.
    Ferreira DM, Darrieux M, Silva DA, Leite LC, Ferreira JM, Ho PL, Miyaji EN, Oliveira ML.
    Clin Vaccine Immunol; 2009 May 05; 16(5):636-45. PubMed ID: 19279169
    [Abstract] [Full Text] [Related]

  • 18. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
    Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.
    Infect Immun; 2013 May 05; 81(5):1625-34. PubMed ID: 23460513
    [Abstract] [Full Text] [Related]

  • 19. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.
    Vaccine; 2015 Feb 04; 33(6):783-8. PubMed ID: 25545593
    [Abstract] [Full Text] [Related]

  • 20. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
    Campos IB, Darrieux M, Ferreira DM, Miyaji EN, Silva DA, Arêas AP, Aires KA, Leite LC, Ho PL, Oliveira ML.
    Microbes Infect; 2008 Apr 04; 10(5):481-8. PubMed ID: 18403234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.